Antiviral Treatment among Older Adults Hospitalized with Influenza, 2006-2012

Objective To describe antiviral use among older, hospitalized adults during six influenza seasons (2006—2012) in Davidson County, Tennessee, USA. Methods Among adults ≥50 years old hospitalized with symptoms of respiratory illness or non-localizing fever, we collected information on provider-initiated influenza testing and nasal/throat swabs for influenza by RT-PCR in a research laboratory, and calculated the proportion treated with antivirals. Results We enrolled 1753 adults hospitalized with acute respiratory illness. Only 26% (457/1753) of enrolled patients had provider-initiated influenza testing. Thirty-eight patients had a positive clinical laboratory test, representing 2.2% of total patients and 8.3% of tested patients. Among the 38 subjects with clinical laboratory-confirmed influenza, 26.3% received antivirals compared to only 4.5% of those with negative clinical influenza tests and 0.7% of those not tested (p<0.001). There were 125 (7.1%) patients who tested positive for influenza in the research laboratory. Of those with research laboratory-confirmed influenza, 0.9%, 2.7%, and 2.8% received antivirals (p=.046) during pre-pandemic, pandemic, and post-pandemic influenza seasons, respectively. Both research laboratory-confirmed influenza (adjusted odds ratio [AOR] 3.04 95%CI 1.26-7.35) and clinical laboratory-confirmed influenza (AOR 3.05, 95%CI 1.07-8.71) were independently associated with antiviral treatment. Severity of disease, presence of a high-risk condition, and symptom duration were not associated with antiviral use. Conclusions In urban Tennessee, antiviral use was low in patients recognized to have influenza by the provider as well as those unrecognized to have influenza. The use of antivirals remained low despite recommendations to treat all hospitalized patients with confirmed or suspected influenza.

[1]  Qingxia Chen,et al.  Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged ≥50 years. , 2015, Journal of Infectious Diseases.

[2]  A. Monto,et al.  Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Tom Jefferson,et al.  Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments , 2014, BMJ : British Medical Journal.

[4]  D. Gravel,et al.  Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic , 2014, Antimicrobial Resistance and Infection Control.

[5]  A. Dugas,et al.  Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients. , 2013, Annals of emergency medicine.

[6]  Qingxia Chen,et al.  Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Marie R. Griffin,et al.  The Burden of Influenza in Young Children, 2004–2009 , 2013, Pediatrics.

[8]  Jo Leonardi-Bee,et al.  Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009–2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients , 2012, The Journal of infectious diseases.

[9]  A. Monto,et al.  Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  L. Balluz,et al.  Self-reported influenza-like illness and receipt of influenza antiviral drugs during the 2009 pandemic, United States, 2009-2010. , 2012, American journal of public health.

[11]  A. Coleman.  Antivirals for Treatment of Influenza: A Systematic Review and Meta-Analysis of Observational Studies , 2012 .

[12]  W. Schaffner,et al.  Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  T. West,et al.  Faculty Opinions recommendation of Accuracy of rapid influenza diagnostic tests: a meta-analysis. , 2012 .

[14]  Hong Zhou,et al.  Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Madhukar Pai,et al.  Accuracy of Rapid Influenza Diagnostic Tests , 2012, Annals of Internal Medicine.

[16]  J. You,et al.  A Cost-Effectiveness Analysis of “Test” versus “Treat” Patients Hospitalized with Suspected Influenza in Hong Kong , 2012, PloS one.

[17]  L. Simonsen,et al.  Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment , 2011, Influenza and other respiratory viruses.

[18]  W. Schaffner,et al.  Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. , 2011, The Journal of infectious diseases.

[19]  A. Monto,et al.  Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities , 2011, PloS one.

[20]  Qingxia Chen,et al.  Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. , 2011, The Journal of infectious diseases.

[21]  L. Gubareva,et al.  Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[22]  K. Poehling,et al.  Failure of Routine Diagnostic Methods to Detect Influenza in Hospitalized Older Adults , 2010, Infection Control &#x0026; Hospital Epidemiology.

[23]  A. Falsey,et al.  The Diagnosis of Viral Respiratory Disease in Older Adults , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Erin Burns,et al.  Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. , 2010, MMWR. Morbidity and mortality weekly report.

[25]  T. Uyeki,et al.  Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

[26]  Stefan Gravenstein,et al.  Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  K. Deichmann,et al.  Effect of rapid influenza testing on the clinical management of paediatric influenza , 2009, Influenza and other respiratory viruses.

[28]  T. Uyeki,et al.  Use of rapid tests and antiviral medications for influenza among primary care providers in the United States , 2009, Influenza and other respiratory viruses.

[29]  Derick R. Peterson,et al.  Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible? , 2007, The Journal of infectious diseases.

[30]  E. Walsh,et al.  Impact of rapid diagnosis on management of adults hospitalized with influenza. , 2006, Archives of internal medicine.

[31]  M. Rothberg,et al.  Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  E. Walsh,et al.  Respiratory syncytial virus infection in elderly and high-risk adults. , 2005, The New England journal of medicine.

[33]  C. Viboud,et al.  Respiratory syncytial virus infection in elderly adults. , 2005, The New England journal of medicine.

[34]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[35]  M. Rothberg,et al.  Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy , 2003, Annals of Internal Medicine.

[36]  K. Monroe,et al.  Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. , 2003, Pediatrics.

[37]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[38]  K G Moons,et al.  Clinical signs and symptoms predicting influenza infection. , 2001, Archives of internal medicine.

[39]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.